1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Cranial Nerve II Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lavie, V; Zalish, M | 1 |
| Belkin, M; Schwartz, M; Yoles, E | 1 |
2 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury.
Topics: Animals; Axons; Cell Survival; Dronabinol; Excitatory Amino Acid Antagonists; Male; Microscopy, Electron; Nerve Degeneration; Nerve Regeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2003 |
HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy.
Topics: Action Potentials; Animals; Axons; Brain Injuries; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Electrophysiology; Energy Metabolism; Evoked Potentials, Visual; Male; NAD; Nerve Crush; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Time Factors | 1996 |